BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 6417232)

  • 1. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
    J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
    Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
    Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
    Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
    Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
    Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
    Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
    Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
    J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine production by human T cell hybridomas.
    Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
    J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
    Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
    J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
    Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
    J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
    J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
    Dean RT; Virelizier JL
    Clin Exp Immunol; 1983 Mar; 51(3):501-10. PubMed ID: 6342884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
    Sanders KM; Littman BH
    J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
    Webb DS; Gerrard TL
    J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.